中国中医药信息杂志2024，Vol.31Issue(9)：79-86,8.DOI:10.19879/j.cnki.1005-5304.202310378
2013-2022年中医药调节核因子-κB研究热点与趋势分析
Analysis on Research Hotspots and Trend of TCM in Regulating Nuclear Factor-κB from 2013 to 2022
摘要
Abstract
Objective To analyze the research trends and frontier of TCM regulation of NF-κB;To provide reference for related research.Methods Relevant literature about TCM regulation of NF-κB was retrieved from CNKI,VIP,Wanfang Data,CBM and Web of Science from January 1,2013 to December 31,2022.VOSviewer 1.6.19 and CiteSpace 6.2.R4 software were used for visualization analysis on authors,institutions and keywords.Results Totally 3 728 articles in Chinese and 995 in English were included,and the number of articles was on the rise.The Chinese and English articles involved 487 and 237 core authors,respectively,forming research teams represented by Yan Guanghai,Liu Jian,Wang Li,and Li Wei,Zhang Li,Zhang Yu,etc.There were 7 and 8 effective clusters in Chinese and English articles respectively.Keyword analysis showed that this research field mainly focused on diseases(inflammatory diseases,tumors,cardiovascular and cerebrovascular diseases,etc.),research methods(in vivo experiment,in vitro experiment)and intervention methods(acupuncture,TCM monomer,TCM compound,etc.).Conclusion TCM regulation of NF-κB mainly focuses on related diseases and intervention methods,and it is a research trend to find drug action targets and conduct experimental verification through network pharmacology and molecular docking technology.关键词
中医药/核因子-κB/CiteSpace/VOSviewer/研究热点/文献计量学Key words
TCM/NF-κB/CiteSpace/VOSviewer/research hotspots/bibliometrics分类
医药卫生引用本文复制引用
雷翰霖,李定祥,阳晶晶,蔡昱哲,邓奕辉..2013-2022年中医药调节核因子-κB研究热点与趋势分析[J].中国中医药信息杂志,2024,31(9):79-86,8.基金项目
国家重点研发计划(2022YFC3501202) （2022YFC3501202）
湖南省科技创新团队项目(2020RC4050) （2020RC4050）
湖南省中医药科研计划项目(E2022010) （E2022010）
湖南研究生科研创新课题(2022CX11) （2022CX11）
